- Home
- NSTS vs VTGN Comparison
NSTS vs VTGN Comparison
Compare NSTS & VTGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NSTS
- VTGN
- Stock Information
- Founded
- NSTS 1921
- VTGN 1998
- Country
- NSTS United States
- VTGN United States
- Employees
- NSTS N/A
- VTGN N/A
- Industry
- NSTS Savings Institutions
- VTGN Biotechnology: Pharmaceutical Preparations
- Sector
- NSTS Finance
- VTGN Health Care
- Exchange
- NSTS Nasdaq
- VTGN Nasdaq
- Market Cap
- NSTS 65.8M
- VTGN 62.9M
- IPO Year
- NSTS N/A
- VTGN N/A
- Fundamental
- Price
- NSTS $11.78
- VTGN $2.24
- Analyst Decision
- NSTS
- VTGN
- Analyst Count
- NSTS 0
- VTGN 0
- Target Price
- NSTS N/A
- VTGN N/A
- AVG Volume (30 Days)
- NSTS 1.6K
- VTGN 89.0K
- Earning Date
- NSTS 05-20-2025
- VTGN 06-10-2025
- Dividend Yield
- NSTS N/A
- VTGN N/A
- EPS Growth
- NSTS N/A
- VTGN N/A
- EPS
- NSTS N/A
- VTGN N/A
- Revenue
- NSTS $8,931,000.00
- VTGN $698,000.00
- Revenue This Year
- NSTS N/A
- VTGN N/A
- Revenue Next Year
- NSTS N/A
- VTGN N/A
- P/E Ratio
- NSTS N/A
- VTGN N/A
- Revenue Growth
- NSTS 82.49
- VTGN N/A
- 52 Week Low
- NSTS $9.37
- VTGN $1.90
- 52 Week High
- NSTS $13.32
- VTGN $4.75
- Technical
- Relative Strength Index (RSI)
- NSTS 53.97
- VTGN 46.94
- Support Level
- NSTS $11.72
- VTGN $2.10
- Resistance Level
- NSTS $11.70
- VTGN $2.45
- Average True Range (ATR)
- NSTS 0.09
- VTGN 0.13
- MACD
- NSTS 0.04
- VTGN 0.02
- Stochastic Oscillator
- NSTS 100.00
- VTGN 53.33
About NSTS NSTS Bancorp Inc.
NSTS Bancorp Inc is a savings and loan holding company regulated Federal Reserve Board. The company was formed to serve as the North Shore Trust and Savings stock holding company. The Bank is a wholly-owned subsidiary of the company and operates as a traditional savings institution focused on serving the banking needs of customers in our market area of Lake County, Illinois and adjacent communities.
About VTGN VistaGen Therapeutics Inc.
Vistagen Therapeutics Inc is a biotechnology firm. The company is neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on deep understanding of nose-to-brain neurocircuitry.